[Pyr1]-Apelin-13, Pro(¹³C₅,¹⁵N) TFA

Cat. No.: HY-P1033S1 Pureza: 99.85%: Ficha de datos
COA

SDS
Instrucciones de manejo
FAQs
Technical Support

[Pyr1]-Apelin-13, Pro(¹³C5,¹⁵N) (TFA) is the ¹³C and ¹⁵N labeled isotope of [Pyr1]-Apelin-13(HY-P1033).[Pyr1]-Apelin-13 is a potent and selective endogenous apelin receptor agonist.

Para uso exclusivo en investigación. No vendemos a pacientes.

[Pyr1]-Apelin-13, Pro(<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N) TFA

[Pyr1]-Apelin-13, Pro(¹³C₅,¹⁵N) TFA Estructura química

Tamaño	Stock	Cantidad
1 mg	En stock	Estimated Time of Arrival: December 31
5 mg	En stock	Estimated Time of Arrival: December 31
10 mg	Obtener un presupuesto
50 mg	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Other Forms of [Pyr1]-Apelin-13, Pro(¹³C₅,¹⁵N) TFA:

[Pyr1]-Apelin-13 In-stock
[Pyr1]-Apelin-13, Gly(15N) TFA Obtener un presupuesto

Recomendaciones destacadas

•Related Small Molecules:

•Related Proteins:

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn

[Pyr1]-Apelin-13, Pro(¹³C5,¹⁵N) (TFA) is the ¹³C and ¹⁵N labeled isotope of [Pyr1]-Apelin-13(HY-P1033).[Pyr1]-Apelin-13 is a potent and selective endogenous apelin receptor agonist^[1].

Application

1. This compound can be used as a tracer.
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

Peso molecular

1539.76 (free acid)

Fòrmula

C₆₄¹³C₅H₁₀₈N₂₁¹⁵NO₁₆S.xC₂HF₃O₂

Unlabeled CAS

217082-60-5

Appearance

Solid

Color

White to off-white

SMILES

O=C([C@@H]1CCC(N1)=O)N[C@@H](CCCNC(N)=N)C(N2[C@@H](CCC2)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CCCCN)C(NCC([15N]3[13C@@H]([13CH2][13CH2][13CH2]3)[13C](N[C@@H](CCSC)C(N4[C@@H](CCC4)C(N[C@H](C(O)=O)CC5=CC=CC=C5)=O)=O)=O)=O)=O)=O)CC6=CN=CN6)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O.[x]

Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

Sealed storage, away from moisture

Powder	-80°C	2 years
	-20°C	1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvente y solubilidad

In Vitro:

H₂O : 100 mg/mL (Need ultrasonic)

Calculadora de molaridad
Calculadora de dilución

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).

Pureza y Documentación

Purity: 99.85%

Select Batch:

Ficha de datos (272 KB) SDS (252 KB)

COA (254 KB) LCMS (92 KB)

Instrucciones de manejo (2659 KB)

Referencias

[1]. Hajimashhadi Z, et al. Chronic administration of [Pyr1] apelin-13 attenuates neuropathic pain after compression spinal cord injury in rats. Neuropeptides. 2017 Feb;61:15-22. [Content Brief]

[2]. Serpooshan V, et al. [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction. Biomaterials. 2015 Jan;37:289-98. [Content Brief]

[3]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]